What Is the APRN’s Role in Managing Patients Receiving Targeted Therapy?

Nicole Ross CRNP, MSN, AOCNP®
Voice

Description

Targeted therapies block the growth of cancer by interfering with specific molecules and may also be referred to as molecularly targeted drugs or precision oncology. Advanced practice RNs (APRNs) must be familiar with the various agents and their side effect profiles, including immunotherapies, hormone therapies, apoptosis inducers, monoclonal antibodies, angiogenesis inhibitors, and signal transduction inhibitors. 

View Article @ voice.ons.org

ONS Voice Articles

ONS's member magazine articles.

View All Voice Articles